PROViatris Inc
stock17.54
-0.10 (-0.57%)
Price as of 13 Oct, 19:51 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Attractive
Attractive investment profile
Technical Analysis
Short-Term Outlook
Bearish
1 bull · 2 bear · 2 neutral
Medium-Term Outlook
Bullish
3 bull · 1 bear · 0 neutral
Price above 50-day MA
Price above 200-day MA
Price below 12-day EMA
Price above 26-day EMA
Neutral momentum zone
MACD below signal line
%K above %D
Price near middle band
Volatility measure — informational only
Market Statistics
Day Change
-0.10
Market Cap
20135117000
Exchange
NASDAQ
Sector
Health Care
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Viatris Inc
What is Viatris Inc?
Viatris Inc is a global healthcare company formed through the merger of Upjohn and Mylan, focusing on providing access to generic and branded medicines. It operates a vast portfolio of established pharmaceutical products across various therapeutic areas, including cardiovascular, infectious disease, and oncology. The company aims to simplify healthcare by balancing a diverse supply chain with a broad reach of affordable treatments.
Is Viatris Inc a good investment?
Viatris offers potential stability through its significant portfolio of well-known established brands and a commitment to shareholder dividends. However, it faces challenges such as high debt levels, stiff competition in the generic drug market, and integration hurdles following its formation. Please remember that this information is for educational purposes only and does not constitute financial or investment advice.
How do you invest in Viatris Inc?
You can invest in Viatris by purchasing shares directly through a standard brokerage account using its ticker symbol VTRS. Alternatively, you may gain exposure to the company by investing in healthcare-focused exchange-traded funds or mutual funds that include Viatris as part of their broader holdings. Ensure you research your preferred brokerage platform's fees and account requirements before initiating a trade.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for VTRS — be the first to start the discussion.
Point & Figure Analysis
Famous Investors Holding VTRS
Ray Dalio
1.70M sh · 0.1% of portfolio
$26.97M
NEW
Ken Griffin
661.0K sh · 0.0% of portfolio
$10.50M
NEW
Ken Griffin
502.3K sh · 0.0% of portfolio
$7.98M
NEW
Ken Griffin
241.8K sh · 0.0% of portfolio
$3.84M
NEW
Mario Gabelli
177.0K sh · 0.0% of portfolio
$2.81M
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.